Rating History for Clovis Oncology (CLVS) by JPMorgan

More Stocks Rated by JPMorgan | Latest Ratings for CLVS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/10/2022 Brian Cheng Downgrade Underweight
(Neutral)		 N/A
(N/A)		 0.98
(0.08)		 -91.84% Details